Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions
檔案
本條目沒有附加檔案。
日期
2019-05-01
類型
系所
期刊名稱
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷期與頁次
第 20 卷第 9 期
ISSN
1422-0067
語言
英文
摘要
Osteoporosis is a major concern all over the world. With aging, a gradual loss of bone mass results in osteopenia and osteoporosis. Heritable factors account for 60-80% of optimal bone mineralization. Modifiable factors, such as weight-bearing exercise, nutrition, body mass, and hormonal milieu, play an important role in the development of osteopenia and osteoporosis in adulthood. Currently, anti-resorptive agents, including estrogen, bisphosphonates, and selective estrogen receptor modulators (SERMs), are the drugs of choice for osteoporosis. Other treatments include parathyroid hormone (PTH) as well as the nutritional support of calcium and vitamin D. New treatments such as tissue-selective estrogen receptor complexes (TSECs) are currently in use too. This review, which is based on a systematic appraisal of the current literature, provides current molecular and genetic opinions on osteoporosis and its medical treatment. It offers evidence-based information to help researchers and clinicians with osteoporosis assessment. However, many issues regarding osteoporosis and its treatment remain unknown or controversial and warrant future investigation.
所屬典藏
期刊論文引用此條目
Chen, L.-R., Ko, N.-Y., & Chen, K.-H. (2019). Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(9), 0. https://doi.org/10.3390/ijms20092213
引用文字依 APA 第 7 版格式自動產生,使用前請再核對。
分享
永久網址:https://ir.lib.nycu.edu.tw/handle/11536/152389